Clare Bailey

Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

Peter A. Campochiaro, David M. Brown, Andrew Pearson et al. · Ophthalmology · 2012 · 493 citations

Ocular Disease, Vitreous Body, Ophthalmology +5

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial

Richard J. McManus, Jonathan Mant, Marloes Franssen et al. · The Lancet · 2018 · 405 citations · Full text

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Andrew Lotery, Sobha Sivaprasad, Abby O’Connell et al. · The Lancet · 2020 · 218 citations · Full text

Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study

Adnan Tufail, Praveen J. Patel, Catherine Egan et al. · BMJ · 2010 · 213 citations · Full text

Sustained Delivery Fluocinolone Acetonide Vitreous Implants

José Cunha‐Vaz, Paul Ashton, Raymond Iezzi et al. · Ophthalmology · 2014 · 152 citations